<SEC-DOCUMENT>9999999997-23-003557-index.html : 20230829 <SEC-HEADER>9999999997-23-003557.hdr.sgml : 20230829 <ACCEPTANCE-DATETIME>20230717160341 ACCESSION NUMBER: 9999999997-23-003557 CONFORMED SUBMISSION TYPE: SEC STAFF LETTER CATEGORY: REDACTED EXHIBIT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230713 ACTION DATE: 20230713 RECEIVED DATE: 20230717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001053691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300645032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SEC STAFF LETTER BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA STREET 2: SUITE 424 CITY: BOSTON STATE: MA ZIP: 02216 BUSINESS PHONE: (617) 744-4400 MAIL ADDRESS: STREET 1: 20 PARK PLAZA STREET 2: SUITE 424 CITY: BOSTON STATE: MA ZIP: 02216 FORMER COMPANY: FORMER CONFORMED NAME: Diffusion Pharmaceuticals Inc. DATE OF NAME CHANGE: 20160115 FORMER COMPANY: FORMER CONFORMED NAME: RestorGenex Corp DATE OF NAME CHANGE: 20140307 FORMER COMPANY: FORMER CONFORMED NAME: Stratus Media Group, Inc DATE OF NAME CHANGE: 20080722 </SEC-HEADER> <DOCUMENT> <TYPE>REDACTED EXHIBIT <SEQUENCE>1 <FILENAME>filename1.pdf <TEXT> Document 1 - file: filename1.pdf
</DOCUMENT> </SEC-DOCUMENT>